GB0912160D0 - Polymer modified macromolecules - Google Patents

Polymer modified macromolecules

Info

Publication number
GB0912160D0
GB0912160D0 GBGB0912160.9A GB0912160A GB0912160D0 GB 0912160 D0 GB0912160 D0 GB 0912160D0 GB 0912160 A GB0912160 A GB 0912160A GB 0912160 D0 GB0912160 D0 GB 0912160D0
Authority
GB
United Kingdom
Prior art keywords
polymer modified
modified macromolecules
polymer
macromolecules
biological macromolecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0912160.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warwick Effect Polymers Ltd
Original Assignee
Warwick Effect Polymers Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warwick Effect Polymers Ltd filed Critical Warwick Effect Polymers Ltd
Priority to GBGB0912160.9A priority Critical patent/GB0912160D0/en
Publication of GB0912160D0 publication Critical patent/GB0912160D0/en
Priority to PCT/GB2010/001338 priority patent/WO2011007133A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00—Macromolecular products derived from proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to processes and compounds for adding a polymer to a biological macromolecule, wherein the biological macromolecule comprises a sulphydryl group or disulphide bond which is reacted with a vinyl moiety attached to the polymer.
GBGB0912160.9A 2009-07-13 2009-07-13 Polymer modified macromolecules Ceased GB0912160D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0912160.9A GB0912160D0 (en) 2009-07-13 2009-07-13 Polymer modified macromolecules
PCT/GB2010/001338 WO2011007133A2 (en) 2009-07-13 2010-07-13 Polymer modified macromolecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0912160.9A GB0912160D0 (en) 2009-07-13 2009-07-13 Polymer modified macromolecules

Publications (1)

Publication Number Publication Date
GB0912160D0 true GB0912160D0 (en) 2009-08-26

Family

ID=41057882

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0912160.9A Ceased GB0912160D0 (en) 2009-07-13 2009-07-13 Polymer modified macromolecules

Country Status (2)

Country Link
GB (1) GB0912160D0 (en)
WO (1) WO2011007133A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110095800A (en) 2010-02-19 2011-08-25 삼성전자주식회사 Method for transmitting video content compressed by codec and device therefor
CN111318185B (en) * 2018-12-17 2022-04-05 中国石油化工股份有限公司 Coating process of graphene filter membrane material with enhanced hydrophilicity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763548A (en) 1995-03-31 1998-06-09 Carnegie-Mellon University (Co)polymers and a novel polymerization process based on atom (or group) transfer radical polymerization
US5807937A (en) 1995-11-15 1998-09-15 Carnegie Mellon University Processes based on atom (or group) transfer radical polymerization and novel (co) polymers having useful structures and properties
ATE207082T1 (en) 1996-06-12 2001-11-15 Univ Warwick POLYMERIZATION CATALYST AND PROCESS
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
MX2008011584A (en) 2006-03-10 2008-12-12 Warwick Effect Polymers Ltd Polymers.

Also Published As

Publication number Publication date
WO2011007133A3 (en) 2011-06-09
WO2011007133A2 (en) 2011-01-20

Similar Documents

Publication Publication Date Title
EP2399940A3 (en) Modified macromolecules and methods of making and using thereof
BR112013000616A2 (en) polymer grafted by nitrogen associative molecules
MY153964A (en) Process for the production of water and solvent-free polymers
WO2012059873A3 (en) Anti-diabetic compounds
MX2013010653A (en) Terminal-modified difunctional sulfur-containing polymers, compositions thereof and methods of use.
MX2010009154A (en) Conjugated factor viii molecules.
BR112014015909A2 (en) composition
WO2010136585A3 (en) Combination of adrenergic receptor agonist -1 or -2, preferably brimonidine with fillers, preferablyhyaluronic acid
MX344246B (en) Method for producing 5-fluorine-1-alkyl-3-fluoralkyl-1h-pyrazol-4 carbolic acid chlorides.
FR2932488B1 (en) CIPO - Patent - 2581626 Canadian Intellectual Property Office Symbol of the Government of Canada CA 2461392 STARCH - BASED THERMOPLASTIC OR ELASTOMERIC COMPOSITIONS AND PROCESS FOR THE PREPARATION OF SUCH COMPOSITIONS.
UA109435C2 (en) STABILIZED AGRICULTURAL OIL DISPERSIONS
MX2012007340A (en) Anti-her3 antibodies and uses thereof.
MY160881A (en) Process for the production of water and solvent-free polymers
WO2011090949A3 (en) Methods and compositions for processing chemical reactions
IN2012DN00775A (en)
MX338828B (en) Masterbatch and process for preparing a polymer composition.
WO2008042289A3 (en) Polymer synthetic technique
MX2009008660A (en) Method for the preparation of therapeutically valuable triphenylbutene derivatives.
EP2554669A4 (en) Novel antibody having modification site introduced therein, and antibody fragment
MX2012006834A (en) Controlled synthesis of polyglutamic acid.
IN2012DN02804A (en)
WO2012003501A3 (en) Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
WO2010118264A3 (en) Multiplexed sites for polymer synthesis
BRPI0910383A2 (en) polyurethane and / or ammonium polycarboanth compounds
WO2013186632A3 (en) Conjugates of biologically active molecules to functionalized polymers

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)